Exploring Psychedelics with a Legal Mind
March 01, 2023
While many psychedelics are classified as Schedule I drugs under the federal Controlled Substances Act, the recent resurgence of interest in their potential therapeutic benefits means the landscape around psychedelics is rapidly evolving. New laws and regulations are proposed and passed at the local, state, and federal levels. Research continues to increase as well, contributing to the questions and perspectives surrounding the various uses of psychedelics. In this interview, Dustin Robinson, Esq., CPA, Managing Principal of Iter Investments; Co-Founder of Nucleus; Founding Partner of Mr. Cannabis Law; and Co-Founder of Mr. Psychedelic Law explains how he navigates the complex legal landscape of psychedelics, the surprises and challenges he encounters, and how he envisions psychedelics in the United States in the near future.
